These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6724718)

  • 1. Cellular immunity in renal failure: depression of lymphocyte transformation by uraemia and methylprednisolone. Intra-individual consistency of lymphocyte responses to the in vitro suppressive effect of steroid.
    Langhoff E; Ladefoged J
    Int Arch Allergy Appl Immunol; 1984; 74(3):241-5. PubMed ID: 6724718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of interleukin-2 and methylprednisolone on in vitro transformation of uremic lymphocytes.
    Langhoff E; Ladefoged J; Odum N
    Int Arch Allergy Appl Immunol; 1986; 81(1):5-11. PubMed ID: 3488966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of haemodialysis on immune response.
    Gombos EA; Jefferson DM; Bhat JG
    Proc Eur Dial Transplant Assoc; 1975; 11():367-73. PubMed ID: 1197260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved lymphocyte transformation in vitro of patients on continuous ambulatory peritoneal dialysis.
    Langhoff E; Ladefoged J
    Proc Eur Dial Transplant Assoc; 1983; 20():230-5. PubMed ID: 6657659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro immune functions in patients with minor, moderate, and severe kidney impairment.
    Langhoff E; Ladefoged J
    APMIS; 1988 Jul; 96(7):655-9. PubMed ID: 3261594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen-stimulated lymphocyte growth and chronic uraemia.
    Gibbs JH; Robertson AJ; Brown RA; Potts RC; Murdoch JC; Stewart WK; Beck JS
    J Clin Lab Immunol; 1982 Oct; 9(1):19-25. PubMed ID: 7175920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host immune status in uraemia. II. Serum factors and lymphocyte transformation.
    Stewart E; Miller TE
    Clin Exp Immunol; 1980 Jul; 41(1):123-9. PubMed ID: 6969146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis.
    Holdsworth SR; Fitzgerald MG; Hosking CS; Atkins RC
    Clin Exp Immunol; 1978 Jul; 33(1):95-101. PubMed ID: 709914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte transformation in human plasma without addition of synthetic medium. A study of immune function in patients with chronic uraemia or diabetes mellitus.
    Sengar DP; Rashid A; Harris JE
    Int Arch Allergy Appl Immunol; 1976; 51(6):732-41. PubMed ID: 137217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro analysis of B lymphocyte function in uraemia.
    Degiannis D; Mowat AM; Galloway E; Tsakiris D; Briggs JD; Junor BJ; Parrott DM
    Clin Exp Immunol; 1987 Nov; 70(2):463-70. PubMed ID: 3322618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid sensitivity of chronic uraemic and renal transplant patients measured by the antibody dependent cellular cytotoxicity reaction.
    Petri I; Csajbók E; Kiss E; Szenohradszky P; Kaiser G; Gál G
    Haematologia (Budap); 1985; 18(4):225-32. PubMed ID: 3915294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic analysis of interleukin 2 (IL-2) production and expression of IL-2 receptors by uraemic and normal lymphocytes.
    Langhoff E; Hofmann B; Odum N; Ladefoged J; Platz P; Ryder LP; Svejgaard A
    Scand J Immunol; 1987 Jan; 25(1):29-36. PubMed ID: 3101170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
    Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
    Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired release of interleukin-6 from human osteoblastic cells in the uraemic milieu.
    Steddon SJ; McIntyre CW; Schroeder NJ; Burrin JM; Cunningham J
    Nephrol Dial Transplant; 2004 Dec; 19(12):3078-83. PubMed ID: 15494357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host immune status in uraemia. I. Cell-mediated immune mechanisms.
    Miller TE; Stewart E
    Clin Exp Immunol; 1980 Jul; 41(1):115-22. PubMed ID: 6449329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of selenium supplementation on immune parameters in chronic uraemic patients on haemodialysis.
    Bonomini M; Forster S; De Risio F; Rychly J; Nebe B; Manfrini V; Klinkmann H; Albertazzi A
    Nephrol Dial Transplant; 1995; 10(9):1654-61. PubMed ID: 8559485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune potential in human uraemia. 2. Changes after regular haemodialysis therapy.
    Byron PR; Mallick NP; Taylor G
    J Clin Pathol; 1976 Sep; 29(9):770-2. PubMed ID: 789408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro reactivity of lymphocytes obtained from uraemic patients maintained by heamodialysis.
    Sengar DP; Rashid A; Harris JE
    Clin Exp Immunol; 1975 Aug; 21(2):298-305. PubMed ID: 126831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are uraemic children immunologically compromised?
    Ensari C; Ekim M; Ikinciogullari A; Tümer N; Ensari A
    Nephron; 2001 Aug; 88(4):379-81. PubMed ID: 11474235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cellular immunity in dialysis patients using the lymphocyte transformation test (LTT) in comparison to conservatively treated patients with chronic terminal renal failure].
    Meissner S; Schwenke H; Witzel E; Achenbach H
    Z Urol Nephrol; 1986 Apr; 79(5):277-86. PubMed ID: 3526744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.